Skip to content

Efficacy of Melatonin Treatment of Nocturia : a randomized controlled study

Efficacy of Melatonin Treatment of Nocturia : a randomized controlled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200317007
Enrollment
60
Registered
2020-03-17
Start date
2020-03-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

side effect side effect

Interventions

Take melatonin 1 hour before bedtime daily for 2 weeks ,Take placebo 1 hour before bedtime daily for 2 weeks
Active Comparator Drug,Placebo Comparator Drug

Sponsors

Siriraj Routine to research fund
Lead Sponsor
Siriraj Routine to research fund
Collaborator

Eligibility

Sex/Gender
Female
Age
55 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients who attend Urogynecology unit, Siriraj Hospital with -Nocturia patients (>1 times per night) -Age at least 55 years old -Welcomed participants

Exclusion criteria

Exclusion criteria: Patients with Neurological or psychological abnormalities History of drug allergy or side effects from melatonin Hepatic or renal dysfunction Uncontrolled diabetes mellitus, diabetes insipidus and cardiovascular disease Currently taking diuretic, tranquillizer, hypnotics or melatonin Urinary tract infection or tumor Pelvic organ prolapse at least stage 3 Pelvic organ tumor Urinary retention Currently smoking Taking medication that interact with pharmacokinetics of melatonin including carbamazepine, quinolone, rifampicin, cimetidine, estrogen

Design outcomes

Primary

MeasureTime frame
Nocturnal urination episode in nocturia patients at 2 weeks after end of taking melatonin or placebo Frequency volume chart

Secondary

MeasureTime frame
Daytime frequency episode at 2 weeks after end of taking melatonin or placebo Frequency volume chart,Night-time urine volume at 2 weeks after end of taking melatonin or placebo Frequency volume chart,24-hour urine volume at 2 weeks after end of taking melatonin or placebo Frequency volume chart,Maximal voided volume : Daytime and night-time at 2 weeks after end of taking melatonin or placebo Frequency volume chart,Thai version Nocturia Quality of Life Questionnaire score at 2 weeks after end of taking melatonin or placebo Thai version Nocturia Quality of Life Questionnaire,Side effect at 2 weeks after end of taking melatonin or placebo ascertainment

Countries

Thailand

Contacts

Public ContactPimchanok Pariyaeksut

Faculty of Medicine, Siriraj hospital, Mahidol University

ppariyaeksut@gmail.com+66812347041

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026